SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Ginkgo Bioworks Holdings, Inc.
Date: Aug. 12, 2025 · CIK: 0001830214 · Accession: 0001628280-25-039872

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289390

Date
August 12, 2025
Author
Steven Coen
Form
CORRESP
Company
Ginkgo Bioworks Holdings, Inc.

Letter

Document Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue 8th Floor Boston, MA 02210 August 12, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Ginkgo Bioworks Holdings, Inc. Registration Statement on Form S-3 (File No. 333-289390) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “ Company ”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 14, 2025, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact Marko Zatylny (marko.zatylny@ropesgray.com) / telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [ Signature page follows ] Very truly yours, GINKGO BIOWORKS HOLDINGS, INC. By: /s/ Steven Coen Name: Steven Coen Title: Chief Financial Officer [ Signature Page to Acceleration Request ]

Show Raw Text
CORRESP
 1
 filename1.htm

 Document Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue 8th Floor Boston, MA 02210 August 12, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Ginkgo Bioworks Holdings, Inc. Registration Statement on Form S-3 (File No. 333-289390) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “ Company ”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 14, 2025, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact Marko Zatylny (marko.zatylny@ropesgray.com) / telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [ Signature page follows ] Very truly yours, GINKGO BIOWORKS HOLDINGS, INC. By: /s/ Steven Coen Name: Steven Coen Title: Chief Financial Officer [ Signature Page to Acceleration Request ]